Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-03-11 @ 10:38 PM
Study NCT ID:
NCT03373760
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2017-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
S1400F
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |